Vijay K Lathi insider trades: Iterum Therapeutics (ITRM) stock buys and sales
Trades on the price chart
Daily close, with an arrow on each day they bought or sold
Companies
Where Vijay reports to the SEC
and 6 more companies
Open-market buys and sales
28 trades reported on SEC Form 4, newest first
| Date | Stock | Type | Shares | Price | Value | Holding | Reported |
|---|---|---|---|---|---|---|---|
| May 30, 2018 | ITRM | ↑ Buy | 384,615 | $13.00 | $5.0M | By New Leaf Biopharma Opportunities II, | May 31, 2018 (1d) |
| May 30, 2018 | ITRM | ↑ Buy | 278,062 | $13.00 | $3.6M | By New Leaf Ventures III, L.P. | May 31, 2018 (1d) |
| Mar 9, 2018 | IRTC | ↓ Sell | 114,018 | $66.44 | $7.6M | Indirect | Mar 12, 2018 (3d) |
| Feb 22, 2018 | IRTC | ↓ Sell | 45,723 | $65.61 | $3.0M | Indirect | Feb 26, 2018 (4d) |
| Feb 21, 2018 | IRTC | ↓ Sell | 169,000 | $62.41 | $10.5M | Indirect | Feb 22, 2018 (1d) |
| Dec 7, 2017 | IRTC | ↓ Sell | 150,000 | $52.57 | $7.9M | Indirect | Dec 7, 2017 (0d) |
| Nov 17, 2017 | IRTC | ↓ Sell | 225,000 | $52.10 | $11.7M | Indirect | Nov 20, 2017 (3d) |
| Sep 13, 2017 | IRTC | ↓ Sell | 34,613 | $49.51 | $1.7M | Indirect | Sep 15, 2017 (2d) |
| Jun 8, 2017 | IRTC | ↓ Sell | 430,624 | $37.59 | $16.2M | Indirect | Jun 8, 2017 (0d) |
| May 16, 2017 | IRTC | ↓ Sell | 645,000 | $34.70 | $22.4M | Indirect | May 16, 2017 (0d) |
| Oct 25, 2016 | IRTC | ↑ Buy | 25,000 | $17.00 | $425K | Indirect | Oct 25, 2016 (0d) |
| Mar 24, 2015 | MEIP | ↓ Sell | 1,601,390 | $1.97 | $3.2M | Direct | Mar 26, 2015 (2d) |
| Dec 18, 2014 | VSAR | ↓ Sell | 150,000 | $19.01 | $2.9M | Direct | Dec 22, 2014 (4d) |
| Dec 9, 2014 | MEIP | ↓ Sell | 79,085 | $6.01 | $476K | Direct | Dec 10, 2014 (1d) |
| Nov 11, 2014 | VSAR | ↓ Sell | 800,000 | $19.37 | $15.5M | Direct | Nov 13, 2014 (2d) |
| Sep 29, 2014 | VSAR | ↓ Sell | 12,556 | $20.02 | $251K | Direct | Oct 1, 2014 (2d) |
| Mar 27, 2014 | VSAR | ↑ Buy | 60,000 | $21.02 | $1.3M | Direct | Mar 28, 2014 (1d) |
| Nov 21, 2013 | MEIP | ↓ Sell | 365,000 | $8.25 | $3.0M | Direct | Nov 25, 2013 (4d) |
| Nov 20, 2013 | RLYP | ↑ Buy | 185,978 | $11.00 | $2.0M | Indirect | Nov 20, 2013 (0d) |
| May 8, 2013 | MEIP | ↓ Sell | 200,000 | $8.57 | $1.7M | Direct | May 8, 2013 (0d) |
| Apr 19, 2013 | MEIP | ↓ Sell | 257,300 | $8.48 | $2.2M | Direct | Apr 22, 2013 (3d) |
| Feb 19, 2013 | MEIP | ↓ Sell | 497,225 | $6.72 | $3.3M | Direct | Feb 20, 2013 (1d) |
| Jul 24, 2012 | DRTX | ↑ Buy | 784,313 | $9.00 | $7.1M | Indirect | Jul 26, 2012 (2d) |
| Jul 19, 2011 | TSPT | ↓ Sell | 245,062 | $4.47 | $1.1M | Direct | Jul 20, 2011 (1d) |
| Jul 14, 2011 | TSPT | ↓ Sell | 209,953 | $4.98 | $1.0M | Direct | Jul 15, 2011 (1d) |
| Oct 19, 2010 | WHRT | ↑ Buy | 2,341,920 | $2.13 | $5.0M | Direct | Oct 21, 2010 (2d) |
| Jan 26, 2010 | WHRT | ↑ Buy | 388,350 | $5.15 | $2.0M | Direct | Jan 28, 2010 (2d) |
| Feb 6, 2006 | SGXP | ↑ Buy | 100,000 | $6.00 | $600K | Indirect | Feb 8, 2006 (2d) |
Each row is one filing's trades in one stock, summed. Shares and prices are as filed, before any later stock split.
Other ITRM insiders
Open-market trades in the last 12 months
About Vijay K Lathi's insider trades
Vijay K Lathi is a 10% owner of Iterum Therapeutics (ITRM). Since Feb 6, 2006, Vijay has reported 9 open-market purchases worth $27.0M and 19 sales worth $115.6M on SEC Form 4. There have been no open-market trades in the last 12 months.
Their filings also include conversions (7 filings), other transactions (5 filings), shares returned to the company (3 filings), option exercises (3 filings). These aren't open-market trades and aren't counted above.
How to read insider trades
Officers, directors and owners of more than 10% of a company must report trades in its stock on SEC Form 4, usually within two business days. Purchases with their own money are the stronger signal: insiders sell for many reasons (taxes, diversification, a house), but buy for one. See every ITRM insider trade, the latest insider trades across the market, or cluster buys, when several insiders buy the same stock within days.